What is PLACEMA?
PLACEMA is a platform for the production and isolation of induced human pluripotent stem cell (iPSC) lines.
PLACEMA is a nonprofit organization whose main objective is to offer cell reprogramming and differentiation services, adjusted both to national and international quality standards, for use by research groups, the pharmaceutical industry and for clinical application.
PLACEMA is the result of a program established by the National Ministry of Science Technology and Productive Innovation (Ministerio Nacional de Ciencia, Tecnología e Innovación Productiva MINCyT). The National Plan for Science Technology and Innovation for 2012 – 2015 has defined technology platforms as: support units for research, equipped with state of the art equipment and staffed by highly trained personnel, created to offer scientific support services linked to research and technology, both for academic institutions as well as for industry.
- To offer cell reprogramming and differentiation services under national and international quality standards, for research groups as well as for the pharmaceutical industry and for clinical application.
- To establish human resource development and training in the field of cell reprogramming and differentiation..
- To develop this field of expertise in Argentina and in the region, with the aim of transferring it to clinical practice and the productive sector.
Unique in Argentina and one of only a handful of similar projects developing in the region, PLACEMA seeks to offer high quality and accessible cell reprogramming services for the international community.
PLACEMA has access to a prestigious international support network, instrumental to its development in a field expanding at such accelerated rate.
We believe that the fields of Cell Therapy and Regenerative Medicine will revolutionize medical practice and that PLACEMA will play a key role in the clinical and commercial development of this new technology, of such high social impact.